AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
KETOROLAC TROMETAMOL
9 registrations across 4 African markets— 6 active
Markets with KETOROLAC TROMETAMOL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DOLAC INJECTION ( Ketorolac Trometamol 30mg) | 🇬🇭Ghana | — | active | Sept 2029 |
| DOLAC INJECTION ( Ketorolac Trometamol 30mg) | 🇬🇭Ghana | — | active | Sept 2029 |
| Panache Injection Injection | 🇳🇬Nigeria | Superior Pharmaceuticals Limited | active | Aug 2028 |
| TORAKET 10 mg TABLETS | 🇿🇦South Africa | Pharmaplan (Pty) Ltd | suspended | Aug 2024 |
| TORAKET 30 mg INJECTIONS | 🇿🇦South Africa | Pharmaplan (Pty) Ltd | suspended | Aug 2024 |
| TRULAC SUSPENSION BUVABLE FLACON DE 10ML | 🇨🇮Côte d'Ivoire | MEDEOR LIFE CARE LLP | expired | Jan 2023 |
| TORA-DOL 1 % | 🇿🇦South Africa | Ascendis Pharma (Pty) Ltd | active | Jan 1900 |
| TORA-DOL 3 % | 🇿🇦South Africa | Ascendis Pharma (Pty) Ltd | active | Jan 1900 |
| TORA-DOL | 🇿🇦South Africa | Ascendis Pharma (Pty) Ltd | active | Jan 1900 |
KETOROLAC TROMETAMOL in Africa — Regulatory Overview
KETOROLAC TROMETAMOL is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Côte d'Ivoire, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.